Product Name :
DCPLA-ME
Description:
DCPLA-ME, the methyl ester form of DCPLA, is a potent PKCε activator for use in the treatment of neurodegenerative diseases.
CAS:
56687-67-3
Molecular Weight:
322.53
Formula:
C21H38O2
Chemical Name:
DCPLA-ME
Smiles :
CCCCCC1CC1CC1CC1CCCCCCCC(=O)OC
InChiKey:
WSVAMWHCPDAWFM-UHFFFAOYSA-N
InChi :
InChI=1S/C21H38O2/c1-3-4-8-11-17-14-19(17)16-20-15-18(20)12-9-6-5-7-10-13-21(22)23-2/h17-20H,3-16H2,1-2H3
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
DCPLA-ME, the methyl ester form of DCPLA, is a potent PKCε activator for use in the treatment of neurodegenerative diseases.|Product information|CAS Number: 56687-67-3|Molecular Weight: 322.53|Formula: C21H38O2|Synonym:|DCPLA methyl ester|Chemical Name: DCPLA-ME|Smiles: CCCCCC1CC1CC1CC1CCCCCCCC(=O)OC|InChiKey: WSVAMWHCPDAWFM-UHFFFAOYSA-N|InChi: InChI=1S/C21H38O2/c1-3-4-8-11-17-14-19(17)16-20-15-18(20)12-9-6-5-7-10-13-21(22)23-2/h17-20H,3-16H2,1-2H3|Technical Data|Appearance: Solid Power.{{Ridaforolimus} site|{Ridaforolimus} Inhibitor|{Ridaforolimus} Activator|{Ridaforolimus} Protocol|{Ridaforolimus} References|{Ridaforolimus} supplier} |Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: Soluble in DMSO|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Ciforadenant} medchemexpress|{Ciforadenant} GPCR/G Protein|{Ciforadenant} Immunology/Inflammation|{Ciforadenant} Protocol|{Ciforadenant} In Vitro|{Ciforadenant} manufacturer} |Shelf Life: ≥12 months if stored properly.PMID:24428212 |Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined.|HS Tariff Code: 382200|References:|Thomas J. Nelson, et al. Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases. WO2015058191A1.Products are for research use only. Not for human use.|